7/2/2013 8:05:53 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Lund, Sweden – 2 July, 2013 – BioInvent International AB (OMXS: BINV) today
announces that it has signed an extension to its 2009 license agreement with
Mitsubishi Tanabe Pharma Corporation for the development of antibodies from
BioInvent's n-CoDeR® library. Under the terms of the extension, Mitsubishi
Tanabe will continue to have access to BioInvent's discovery and development
technology platform for a further two years and can develop up to eight antibody
Help employers find you! Check out all the jobs and post your resume.
comments powered by